Consistent with this finding, re-introduction of wild-type p53 in ASCL1-high or NEUROD1-high human SCLC cell lines induced cell death predominantly in the ASCL1 subtype, while no measurable decrease in cell viability was observed in NEUROD1+ cells. Here, ASCL1 is linked to small cell lung carcinoma.